Please assess the completion status of the following clinical trial:

Trial Title: Dexamethasone Compared to Non-steroidal Anti-inflammatory Drugs in the Treatment of Acute Pericarditis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient with first presentation of acute pericarditis (both idiopathic and post pericardiectomy)~* Patients diagnosed according to accepted clinical findings: 2 of the 4 following criteria: chest pain, pericardial friction rub, ECG changes typical for pericarditis and/or pericardial effusion.~* Patients over the age of 18 years~Exclusion Criteria:~* Patient with Uncontrolled Diabetes (as defined as hyperglycaemia \>300mg/dl at presentation or HBA1C\>9% (if known))~* Patients with a known allergy to steroid therapy~* Patient with a known allergy to NSAID therapy~* Patients with a known contraindication to colchicine therapy~* Pregnancy or lactating women~* Patients with systemic fungal infection~* Patients with a known pericardial effusion of tuberculous, purulent, or neoplastic causes~* Patients with chronic steroid use~* Patients with a known rheumatological disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Conventional Therapy (Type: ACTIVE_COMPARATOR): Ibuprofen 600mg every 8 hours for one week followed by tapering of dose by 200mg every week (3 weeks of therapy), in addition to Colchicine 0.5mg daily (\<70kg) or 0.5mg twice daily (\>70kg) for 3 months
- Dexamethasone therapy (Type: EXPERIMENTAL): Dexamethasone therapy 20 mg once daily per os for 4 day in addition to colchicine therapy for 3 months 0.5mg daily (\<70kg) or 0.5mg twice daily (\>70kg)

Based on this trial design, predict the completion outcome and termination type (if applicable).